Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Sivelestat Sodium Hydrate
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Undisclosed
Sponsor : Peking University | Shanghai Huilun Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 29, 2024
Lead Product(s) : Sivelestat Sodium Hydrate
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Undisclosed
Sponsor : Peking University | Shanghai Huilun Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable